Background: Deep brain stimulation (DBS) of the caudal zona incerta (cZi) is a relatively unexplored and promising treatment in patients with severe essential tremor (ET). Preliminary data further indicate that the ability to produce language may be slightly affected by the treatment. Objective: To evaluate the effects on verbal fluency following cZi DBS in patients with ET. Method: Seventeen consecutive patients who had undergone DBS of the cZi for ET were tested regarding verbal fluency before surgery, 3 days after surgery and after 1 year. Ten patients were also evaluated by comparing performance on versus off stimulation after 1 year. Results: The total verbal fluency score decreased slightly, but significantly, from 22.7 (SD = 10.9) before surgery to 18.1 (SD = 7.5) 3 days after surgery (p = 0.036). After 1 year the score was nonsignificantly decreased to 20.1 (SD = 9.7, p = 0.2678). There was no detectable difference between stimulation on and off after 1 year. Conclusion: There was a tendency of an immediate and mostly transient postoperative decline in verbal fluency following cZi DBS for ET. In some of the patients this reduction was, however, more pronounced and also sustained over time.

1.
Weaver FM, Follett K, Stern M, Hur K, Harris C, Marks WJ Jr, Rothlind J, Sagher O, Reda D, Moy CS, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, Holloway K, Samii A, Horn S, Bronstein J, Stoner G, Heemskerk J, Huang GD: Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 2009;301:63–73.
2.
Videnovic A, Metman LV: Deep brain stimulation for Parkinson’s disease: prevalence of adverse events and need for standardized reporting. Mov Disord 2008;23:343–349.
3.
Volkmann J, Daniels C, Witt K: Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease. Nat Rev Neurol 2010;6:487–498.
4.
Parsons TD, Rogers SA, Braaten AJ, Woods SP, Troster AI: Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson’s disease: a meta-analysis. Lancet Neurol 2006;5:578–588.
5.
Rothlind JC, Cockshott RW, Starr PA, Marks WJ Jr: Neuropsychological performance following staged bilateral pallidal or subthalamic nucleus deep brain stimulation for Parkinson’s disease. J Int Neuropsychol Soc 2007;13:68–79.
6.
Schuurman PR, Bruins J, Merkus MP, Bosch DA, Speelman JD: A comparison of neuropsychological effects of thalamotomy and thalamic stimulation. Neurology 2002;59:1232–1239.
7.
Troster AI, Woods SP, Fields JA, Hanisch C, Beatty WW: Declines in switching underlie verbal fluency changes after unilateral pallidal surgery in Parkinson’s disease. Brain Cogn 2002;50:207–217.
8.
Fields JA, Troster AI, Woods SP, Higginson CI, Wilkinson SB, Lyons KE, Koller WC, Pahwa R: Neuropsychological and quality of life outcomes 12 months after unilateral thalamic stimulation for essential tremor. J Neurol Neurosurg Psychiatry 2003;74:305–311.
9.
Blomstedt P, Sandvik U, Fytagoridis A, Tisch S: The posterior subthalamic area in the treatment of movement disorders: past, present, and future. Neurosurgery 2009;64:1029–1038.
10.
Fytagoridis A, Blomstedt P: Complications and side effects of deep brain stimulation in the posterior subthalamic area. Stereotact Funct Neurosurg 2010;88:88–93.
11.
Deuschl G, Bain P, Brin M: Consensus statement of the Movement Disorder Society on Tremor. Ad hoc scientific committee. Mov Disord 1998;13(suppl 3):2–23.
12.
Blomstedt P, Sandvik U, Tisch S: Deep brain stimulation in the posterior subthalamic area in the treatment of essential tremor. Mov Disord 2010;25:1350–1356.
13.
Fytagoridis A, Sandvik U, Astrom M, Bergenheim T, Blomstedt P: Long-term follow-up of deep brain stimulation of the caudal zona incerta for essential tremor. J Neurol Neurosurg Psychiatry 2012;83:258–262.
14.
Witt K, Daniels C, Reiff J, Krack P, Volkmann J, Pinsker MO, Krause M, Tronnier V, Kloss M, Schnitzler A, Wojtecki L, Botzel K, Danek A, Hilker R, Sturm V, Kupsch A, Karner E, Deuschl G: Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson’s disease: a randomised, multicentre study. Lancet Neurol 2008;7:605–614.
15.
Troster AI, Woods SP, Fields JA, Lyons KE, Pahwa R, Higginson CI, Koller WC: Neuropsychological deficits in essential tremor: an expression of cerebello-thalamo-cortical pathophysiology? Eur J Neurol 2002;9:143–151.
16.
Louis ED: Essential tremor as a neuropsychiatric disorder. J Neurol Sci 2010;289:144–148.
17.
Bäckman L-G, Nyberg L: Semantic memory function across the adult life span. Eur Psychol 1996;1:27–33.
18.
Blomstedt P, Sandvik U, Fytagoridis A, Tisch S: The posterior subthalamic area in the treatment of movement disorders: past, present, and future. Neurosurgery 2009;64:1029–1038, discussion pp 1038–1042.
19.
Velasco FC, Molina-Negro P, Bertrand C, Hardy J: Further definition of the subthalamic target for arrest of tremor. J Neurosurg 1972;36:184–191.
20.
Blomstedt P, Fytagoridis A, Tisch S: Deep brain stimulation of the posterior subthalamic area in the treatment of tremor. Acta Neurochir (Wien) 2009;151:31–36.
21.
Bhatnagar S, Buckingham H: Neurogenic stuttering: its reticular modulation. Curr Neurol Neurosci Rep 2010;10:491–498.
22.
Crinion J, Turner R, Grogan A, Hanakawa T, Noppeney U, Devlin JT, Aso T, Urayama S, Fukuyama H, Stockton K, Usui K, Green DW, Price CJ: Language control in the bilingual brain. Science 2006;312:1537–1540.
23.
Bell DS: Speech functions of the thalamus inferred from the effects of thalamotomy. Brain 1968;91:619–638.
24.
Samra K, Riklan M, Levita E, Zimmerman J, Waltz JM, Bergmann L, Cooper IS: Language and speech correlates of anatomically verified lesions in thalamic surgery for parkinsonism. J Speech Hear Res 1969;12:510–540.
25.
Vilkki J, Laitinen LV: Differential effects of left and right ventrolateral thalamotomy on receptive and expressive verbal performances and face-matching. Neuropsychologia 1974;12:11–19.
26.
Ojemann GA, Ward AA Jr: Speech representation in ventrolateral thalamus. Brain 1971;94:669–680.
27.
Hugdahl K, Wester K, Asbjornsen A: The role of the left and right thalamus in language asymmetry: dichotic listening in Parkinson patients undergoing stereotactic thalamotomy. Brain Lang 1990;39:1–13.
28.
Ojemann GA, Hoyenga KB, Ward AA Jr: Prediction of short-term verbal memory disturbance after ventrolateral thalamotomy. J Neurosurg 1971;35:203–210.
29.
Vilkki J, Laitinen LV: Effects of pulvinotomy and ventrolateral thalamotomy on some cognitive functions. Neuropsychologia 1976;14:67–78.
30.
Selby G: Stereotactic surgery for the relief of Parkinson’s disease. 2. An analysis of the results in a series of 303 patients (413 operations). J Neurol Sci 1967;5:343–375.
31.
Johnson MD, Ojemann GA: The role of the human thalamus in language and memory: evidence from electrophysiological studies. Brain Cogn 2000;42:218–230.
32.
Fytagoridis A, Astrom M, Wardell K, Blomstedt P: Stimulation-induced side effects in the posterior subthalamic area: distribution, characteristics and visualization. Clin Neurol Neurosurg 2012 May 17, E-pub ahead of print.
33.
Blomstedt P, Fytagoridis A, Astrom M, Linder J, Forsgren L, Hariz MI: Unilateral caudal zona incerta deep brain stimulation for parkinsonian tremor. Parkinsonism Relat Disord 2012 Jun 16, E-pub ahead of print.
34.
Morel A: Stereotactic atlas of the human thalamus and basal ganglia. New York, Informa Healthcare, 2007.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.